Holen Sie sich die Stockscreener-App
3.25
4.84%
0.15
Handel nachbörslich:
3.25
Schlusskurs vom Vortag:
$3.10
Offen:
$3.11
24-Stunden-Volumen:
612.77K
Relative Volume:
0.54
Marktkapitalisierung:
$411.64M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-36.11
EPS:
-0.09
Netto-Cashflow:
$454.00K
1W Leistung:
+0.00%
1M Leistung:
+10.17%
6M Leistung:
-43.67%
1J Leistung:
-49.06%
1-Tages-Spanne:
$3.09
$3.26
1-Wochen-Bereich:
$3.09
$3.375
52-Wochen-Spanne:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Vergleichen Sie CTKB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.25 | 411.64M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-31 | Herabstufung | Goldman | Buy → Sell |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
What drives Cytek Biosciences Inc. stock priceFree Stock Market Return Analysis - jammulinksnews.com
Cytek Biosciences Inc. Stock Analysis and ForecastHigh-profit capital plays - jammulinksnews.com
What analysts say about Cytek Biosciences Inc. stockOutstanding trading profits - jammulinksnews.com
Is Cytek Biosciences Inc. a good long term investmentExceptional risk-adjusted gains - Autocar Professional
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Acquired by Principal Financial Group Inc. - Defense World
Should I buy Cytek Biosciences Inc. stock before earningsLow Risk Profit Ideas - Newser
Teacher Retirement System of Texas Decreases Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
How Cytek Biosciences Inc. stock performs during market volatilityDaily Swing Candidates - Newser
What makes Cytek Biosciences Inc. stock price move sharplyFree Expert-Led Investment Training - Newser
Why Cytek Biosciences Inc. stock attracts strong analyst attentionFree Financial Group - Newser
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by New York State Teachers Retirement System - Defense World
Wealth Enhancement Advisory Services LLC Invests $63,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
MDxHealth names Michael Holder to board, CFO Ron Kalfus to depart - Investing.com
Research device company to relocate local office to Bellevue - The Business Journals
3 Promising Penny Stocks With Market Caps At Least $300M - Yahoo Finance
Cytek Biosciences Elects New Directors at Annual Meeting - TipRanks
Ratios Revealed: Decoding Cytek BioSciences Inc (CTKB)’s Financial Health - DWinneX
Flow Cytometer | Cytek Biosciences Inc. | Products - Photonics Spectra
Cytek Biosciences at Goldman Sachs Conference: Growth Amidst Challenges By Investing.com - Investing.com Canada
Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener
Cytek Biosciences (CTKB) Faced Challenges from NIH Funding Reductions - Insider Monkey
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 22,433 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences Plunges 10.18% Amid Product Discontinuation Concerns - AInvest
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
Insider Buying: William Mccombe Acquires 35,000 Shares of Cytek Biosciences Inc (CTKB) - GuruFocus
Bank of America Corp DE Boosts Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences Leads Our Top 3 Penny Stock Selections - Yahoo Finance
ProShare Advisors LLC Has $235,000 Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Jane Street Group LLC - Defense World
Ameriprise Financial Inc. Has $1.62 Million Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (CTKB) Elevates Cell Analysis with New Aurora Evo System - MSN
Optimizing Lab Efficiency with Cytek's Aurora Evo Flow Cytometer - Lab Manager
The Market Doesn't Like What It Sees From Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Revenues Yet As Shares Tumble 31% - simplywall.st
Cytek announces new full spectrum flow cytometer - SelectScience
Where are the Opportunities in (CTKB) - news.stocktradersdaily.com
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):